Friday,Par Pharmaceutical Companies Inc. (PRX) said its third-quarter net income surged to $26.3 million or $0.76 per share from $0.5 million or $0.01 per share in the prior year period. On average, 8 analysts polled by Thomson Reuters expected the company to report earnings of $0.49 per share for the quarter.
Total revenues for the quarter increased 98% to $294.8 million from $149.0 million in the comparable period. Seven analysts estimated revenues of $290.44 million for the quarter.
For comments and feedback: editorial@rttnews.com